Global Cannabis Market Size, Share, Opportunities, And Trends By End-Use (Medicinal, Recreational), And By Country - Forecasts From 2025 To 2030

Cannabis Market Size:

The Cannabis Market is expected to grow from US$59.603 billion in 2025 to US$132.935 billion in 2030, at a CAGR of 17.40%.

Cannabis Market Trends:

Cannabis is a psychoactive substance extracted from the cannabis plant native to Central and South Asia. It is known by many other names, such as hemp (industrial name), marijuana, grass, CBD, etc. Since ancient times, cannabis has also been used in traditional remedy preparations, entheogenic use, and recreational use. Cannabis can be consumed orally, through vapors, or as an extract. There are a variety of psychological and physiological effects associated with cannabis consumption, such as altered states of consciousness, euphoria, trouble focusing, impaired balance and fine psychomotor control, reduced short-term memory, relaxation, and increased appetite.

Legal growers & producers, customers, independent industrial standards bodies, auxiliary goods and service providers, regulators, and experts on cannabis and hemp, its industrial derivative, comprise the cannabis business. Regulatory limitations have hindered the cannabis business for most of recent history, but as more countries allow medicinal and adult use, the legal cannabis sector has grown quickly. Therefore, the rising legalization of cannabis products for medicinal purposes in various countries is the primary reason driving the growth of the global market during the projection period.

Different segments covered under the cannabis market report are as below:

• By End-Use
  • Medicinal
  • Recreational
• By Country
  • USA
  • Canada
  • Germany
  • United Kingdom
  • Spain
  • Others

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. CANNABIS MARKET BY TYPE

4.1. Introduction

4.2. Flowers/Buds

4.3. Concentrates

5. CANNABIS MARKET BY END-USER

5.1. Introduction

5.2. Medical

5.3. Recreational

5.4. Industrial Hemp

6. CANNABIS MARKET BY COMPONENT

6.1. Introduction

6.2. THC-Dominant

6.3. Balanced THC and CBD

6.4. CBD-Dominant

7. CANNABIS MARKET BY GEOGRAPHY

7.1. Introduction

7.2. North America

7.2.1. By Type

7.2.2. By End-User

7.2.3. By Component

7.2.4. By Country

7.2.4.1. USA

7.2.4.2. Canada

7.2.4.3. Mexico

7.3. South America

7.3.1. By Type

7.3.2. By End-User

7.3.3. By Component

7.3.4. By Country

7.3.4.1. Brazil

7.3.4.2. Argentina

7.3.4.3. Others

7.4. Europe

7.4.1. By Type

7.4.2. By End-User

7.4.3. By Component

7.4.4. By Country

7.4.4.1. United Kingdom

7.4.4.2. Germany

7.4.4.3. France

7.4.4.4. Spain

7.4.4.5. Others

7.5. Middle East and Africa

7.5.1. By Type

7.5.2. By End-User

7.5.3. By Component

7.5.4. By Country

7.5.4.1. Saudi Arabia

7.5.4.2. UAE

7.5.4.3. Others

7.6. Asia Pacific

7.6.1. By Type

7.6.2. By End-User

7.6.3. By Component

7.6.4. By Country

7.6.4.1. China

7.6.4.2. Japan

7.6.4.3. India

7.6.4.4. South Korea

7.6.4.5. Taiwan

7.6.4.6. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Market Share Analysis

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. Aurora Cannabis Inc

9.2. Tilary, Inc

9.3. Canopy Growth Corporation

9.4. CannTrust Holdings Inc

9.5. VIVI Cannabis Inc

9.6. Cronos Group Inc

9.7. Jazz Pharmaceuticals

9.8. OrganiGram Holdings

9.9. Lexaria Corp.

9.10. ABcann Medicinals Inc

10. APPENDIX

10.1. Currency 

10.2. Assumptions

10.3. Base and Forecast Years Timeline

10.4. Key Benefits for the Stakeholders

10.5. Research Methodology 

10.6. Abbreviations

Aurora Cannabis Inc.

Tilary, Inc.

Canopy Growth Corporation

CannTrust Holdings Inc.

VIVI Cannabis Inc.

Cronos Group Inc.

Jazz Pharmaceuticals

OrganiGram Holdings

Lexaria Corp.

ABcann Medicinals Inc.